• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

咪唑并吡啶,一种具有潜在药用应用和结构活性关系 (SAR) 的有前途的支架:最新进展。

Imidazopyridine, a promising scaffold with potential medicinal applications and structural activity relationship (SAR): recent advances.

机构信息

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Punjab, India.

Department of Pharmaceutical Sciences, School of Applied Sciences and Technology, University of Kashmir, Srinagar, J & K, India.

出版信息

J Biomol Struct Dyn. 2022;40(24):14279-14302. doi: 10.1080/07391102.2021.1997818. Epub 2021 Nov 15.

DOI:10.1080/07391102.2021.1997818
PMID:34779710
Abstract

Imidazopyridine scaffold has gained tremendous importance over the past few decades. Imidazopyridines have been expeditiously used for the rationale design and development of novel synthetic analogs for various therapeutic disorders. A wide variety of imidazopyridine derivatives have been developed as potential anti-cancer, anti-diabetic, anti-tubercular, anti-microbial, anti-viral, anti-inflammatory, central nervous system (CNS) agents besides other chemotherapeutic agents. Imidazopyridine heterocyclic system acts as a key pharmacophore motif for the identification and optimization of lead structures to increase medicinal chemistry toolbox. The present review highlights the medicinal significances of imidazopyridines for their rationale development as lead molecules with improved therapeutic efficacies. This review further emphasis on the structure-activity relationships (SARs) of the various designed imidazopyridines to establish a relationship between the key structural features versus the biological activities.Communicated by Ramaswamy H. Sarma.

摘要

咪唑并吡啶支架在过去几十年中变得非常重要。咪唑并吡啶已被迅速用于各种治疗障碍的新型合成类似物的合理设计和开发。已经开发出各种各样的咪唑并吡啶衍生物作为潜在的抗癌、抗糖尿病、抗结核、抗菌、抗病毒、抗炎、中枢神经系统 (CNS) 药物以及其他化疗药物。咪唑并吡啶杂环系统作为识别和优化先导结构以增加药物化学工具箱的关键药效团基序。本综述强调了咪唑并吡啶的药用意义,因为它们作为具有改善治疗效果的先导分子得到了合理的开发。本综述进一步强调了各种设计的咪唑并吡啶的构效关系 (SAR),以建立关键结构特征与生物活性之间的关系。由 Ramaswamy H. Sarma 传达。

相似文献

1
Imidazopyridine, a promising scaffold with potential medicinal applications and structural activity relationship (SAR): recent advances.咪唑并吡啶,一种具有潜在药用应用和结构活性关系 (SAR) 的有前途的支架:最新进展。
J Biomol Struct Dyn. 2022;40(24):14279-14302. doi: 10.1080/07391102.2021.1997818. Epub 2021 Nov 15.
2
Imidazopyridines as a source of biological activity and their pharmacological potentials-Infrared and Raman spectroscopic evidence of their content in pharmaceuticals and plant materials.作为生物活性来源的咪唑并吡啶及其药理潜力——药物和植物材料中其含量的红外和拉曼光谱证据。
Bioorg Med Chem. 2015 Sep 15;23(18):6087-99. doi: 10.1016/j.bmc.2015.07.045. Epub 2015 Jul 29.
3
Imidazo[1,2-A]Pyridine: Potent Biological Activity, SAR and Docking Investigations (2017-2022).咪唑并[1,2-a]吡啶:强大的生物活性、SAR 和对接研究(2017-2022 年)。
Infect Disord Drug Targets. 2024;24(8):e200324228067. doi: 10.2174/0118715265274067240223040333.
4
Discovery of imidazopyridine derivatives as novel c-Met kinase inhibitors: Synthesis, SAR study, and biological activity.发现新型 c-Met 激酶抑制剂——咪唑并吡啶衍生物:合成、SAR 研究及生物活性。
Bioorg Chem. 2017 Feb;70:126-132. doi: 10.1016/j.bioorg.2016.12.002. Epub 2016 Dec 19.
5
Pharmacological Potential and Synthetic Approaches of Imidazo[4,5-b]pyridine and Imidazo[4,5-c]pyridine Derivatives.咪唑并[4,5 - b]吡啶和咪唑并[4,5 - c]吡啶衍生物的药理潜力与合成方法
Molecules. 2017 Mar 4;22(3):399. doi: 10.3390/molecules22030399.
6
Imidazopyridine-based kinase inhibitors as potential anticancer agents: A review.基于咪唑并吡啶的激酶抑制剂作为潜在的抗癌药物:综述。
Bioorg Chem. 2023 Nov;140:106831. doi: 10.1016/j.bioorg.2023.106831. Epub 2023 Sep 3.
7
Exploration of imidazole and imidazopyridine dimers as anticancer agents: Design, synthesis, and structure-activity relationship study.咪唑和咪唑吡啶二聚体作为抗癌剂的探索:设计、合成和构效关系研究。
Arch Pharm (Weinheim). 2019 Dec;352(12):e1900011. doi: 10.1002/ardp.201900011. Epub 2019 Oct 9.
8
Design, synthesis and anti-HBV activity evaluation of new substituted imidazo[4,5-b]pyridines.新型取代咪唑并[4,5-b]吡啶的设计、合成与抗 HBV 活性评价。
Bioorg Chem. 2020 May;98:103580. doi: 10.1016/j.bioorg.2020.103580. Epub 2020 Jan 28.
9
Pyridines and Imidazopyridines with Medicinal Significance.具有药用意义的吡啶和咪唑并吡啶。
Curr Top Med Chem. 2016;16(28):3274-3302. doi: 10.2174/1568026616666160506145141.
10
Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors.作为强效和选择性波罗样激酶(PLK)抑制剂的咪唑并吡啶衍生物
Bioorg Med Chem Lett. 2009 Aug 15;19(16):4673-8. doi: 10.1016/j.bmcl.2009.06.084. Epub 2009 Jun 25.

引用本文的文献

1
Recent advancements in the development of next-generation dual-targeting antibacterial agents.下一代双靶点抗菌剂研发的最新进展。
RSC Med Chem. 2025 Feb 5. doi: 10.1039/d4md00934g.
2
Synthesis and biological activities of 3-aminoimidazo[1,2-α]pyridine compounds.3-氨基咪唑并[1,2-α]吡啶化合物的合成及生物活性
BMC Chem. 2025 Feb 22;19(1):48. doi: 10.1186/s13065-025-01412-6.
3
Identification of a New Promising BAG3 Modulator Featuring the Imidazopyridine Scaffold.鉴定一种新型有前途的 BAG3 调节剂,其特征为咪唑并吡啶骨架。
Molecules. 2024 Oct 25;29(21):5051. doi: 10.3390/molecules29215051.
4
Synthesis of 6- or 8-Carboxamido Derivatives of Imidazo[1,2-]pyridines via a Heterogeneous Catalytic Aminocarbonylation Reaction.通过多相催化氨甲酰化反应合成咪唑并[1,2 - ]吡啶的6 - 或8 - 羧酰胺衍生物
Molecules. 2024 Oct 25;29(21):5048. doi: 10.3390/molecules29215048.
5
Imidazopyrimidine: from a relatively exotic scaffold to an evolving structural motif in drug discovery.咪唑并嘧啶:从相对奇特的骨架到药物研发中不断演变的结构基序。
RSC Med Chem. 2024 Mar 13;15(5):1488-1507. doi: 10.1039/d3md00718a. eCollection 2024 May 22.
6
Synthesis of Membrane-Permeable Macrocyclic Peptides via Imidazopyridinium Grafting.通过亚咪唑吡啶鎓接枝合成可透过细胞膜的大环肽。
J Am Chem Soc. 2024 May 29;146(21):14633-14644. doi: 10.1021/jacs.4c01920. Epub 2024 May 16.
7
Selenium-Containing (Hetero)Aryl Hybrids as Potential Antileishmanial Drug Candidates: In Vitro Screening against .含硒(杂)芳基杂化物作为潜在的抗利什曼原虫药物候选物:体外筛选……
Biomedicines. 2024 Jan 17;12(1):213. doi: 10.3390/biomedicines12010213.
8
Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy.鉴定一种基于咪唑并吡啶的化合物,作为一种口服选择性雌激素受体降解剂用于乳腺癌治疗。
Cancer Res Commun. 2023 Jul 27;3(7):1378-1396. doi: 10.1158/2767-9764.CRC-23-0111. eCollection 2023 Jul.
9
De Novo Design of Imidazopyridine-Tethered Pyrazolines That Target Phosphorylation of STAT3 in Human Breast Cancer Cells.靶向人乳腺癌细胞中STAT3磷酸化的咪唑并吡啶连接的吡唑啉的从头设计
Bioengineering (Basel). 2023 Jan 24;10(2):159. doi: 10.3390/bioengineering10020159.